TrialCirculation research2017

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

Victoria Florea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.